AIDS/HIV Vaccines
New findings in the area of AIDS/HIV vaccines described
Published in AIDS Weekly, January 24th, 2005
Study 1: Scientists have developed a method for producing Lentiviruses that are limited to a single cycle of infection.
"We have devised a novel approach for producing simian immunodeficiency virus (SIV) strains and, potentially, human immunodeficiency virus type 1 (HIV-1) strains that are limited to a single cycle of infection. Unlike previous lentiviral vectors, our single-cycle SIV is capable of expressing eight of the nine viral gene products and infected cells release immature virus particles that are unable to complete subsequent rounds of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-01-24)
More Articles from AIDS Weekly
- HIV/AIDS Prevention
Multifaceted intervention strategy associated with lower HIV rates - HIV/AIDS Therapy
Deferring HAART initiation until CD4 cells drop below 200mm3 is detrimental - HIV/AIDS-Associated Infection
Saquinavir & miconazole synergistic against C. albicans & C. neoformans - HIV/AIDS-Related Nutrition
Vitamins C and E protect against AZT-induced oxidative stress - Advocacy
AIDS group to call for ban on consumer drug advertising - Business & Finance
HIV test maker sees Q4 revenue, margin gains; 140% increase in HIV product sales - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
